These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 17724971)

  • 1. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus.
    Newman CJ; Kennedy A; Walsh M; O'Brien T; Lynch B; Hensey O
    J Pediatr Orthop; 2007 Dec; 27(8):882-5. PubMed ID: 18209608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
    Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
    J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin and cerebral palsy: time for reflection?
    Gough M; Fairhurst C; Shortland AP
    Dev Med Child Neurol; 2005 Oct; 47(10):709-12. PubMed ID: 16174320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
    Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
    Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
    Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy.
    Balkrishnan R; Manuel JC; Smith BP; Camacho FT; Koman LA
    J Surg Orthop Adv; 2004; 13(2):76-80. PubMed ID: 15281403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy.
    Kim H; Lee Y; Weiner D; Kaye R; Cahill AM; Yudkoff M
    Arch Phys Med Rehabil; 2006 Jan; 87(1):141-4. PubMed ID: 16401453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J; Hordyńska E; Swoboda A
    Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.